Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04361045 · ClinicalTrials.gov registry record · NA
StriveWeekly: Self-Guided Online Intervention for Anxiety, Depression, and Stress in University Students
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 1,631
- Enrollment target
NCT04361045: Completed NA study, sponsored by University of California, Los Angeles.
NCT04361045 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 1,631 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04361045, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,631 participants
- Enrollment target
Study Summary
This study was a randomized controlled trial of an original online mental health promotion program. This study aimed to: 1) establish program effectiveness by examining symptom change between conditions and 2) examine predictors of symptom change. The program was previously tested in open trial feasibility study by the same Principal Investigator and has since been rebuilt as informed by feasibility findings and participant qualitative feedback. Participants were randomly assigned to either a waitlist condition or eight weeks of the intervention condition. Baseline, posttest, and follow-up electronic surveys collected self-reported symptoms of stress, anxiety, and depression. Motivational variables were also assessed at baseline and then tested as moderators of intervention effects.
Primary Outcome
This 21-item self-report measure assesses symptoms of depression, anxiety, and stress. Individual items are rated 0 (Did not apply to me at all) to 3 (Applied to me very much or most of the time), with total scores ranging 0 - 63. Lower scores at posttest relative to baseline indicate improvement.
Interventions
- BEHAVIORAL StriveWeekly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,631 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2018-03-18 |
| Phase | NA |
What the finished NCT04361045 record still lists
NCT04361045 is an interventional study that assigns participants to a tested intervention. Its 1,631 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher).
The record links to 0 conditions, and to 1 intervention - of which StriveWeekly is the first listed.
NCT04361045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04361045 about?
NCT04361045 is a clinical study titled "StriveWeekly: Self-Guided Online Intervention for Anxiety, Depression, and Stress in University Students". This study was a randomized controlled trial of an original online mental health promotion program. This study aimed to: 1) establish program effectiveness by examining symptom change between conditions and 2) examine predictors of symptom change. The program was previously tested in open trial feas...
What is the current status of trial NCT04361045?
This trial is currently completed. It is a NA study. The enrollment target is 1,631 participants. The study started on 2017-09-14. Estimated completion is 2018-03-18.
What interventions are being tested in trial NCT04361045?
The interventions under investigation include: StriveWeekly (BEHAVIORAL).
Who is sponsoring clinical trial NCT04361045?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04361045's enrollment target sits among peer trials
1,631 63rd of 2000 higher than 1,938 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI